- CAR-T is an innovative blood cancer treatment that harnesses the power of the patient's own immune system. Patients' T-cells are genetically modified to eliminate cancer cells. This cutting-edge technology offers hopeful prospects to patients in whom other therapies are unsuccessful or inadequate.We are therefore working with great enthusiasm on expanding our capacity for CAR-T treatments in Europe, both at our existing site in Beerse and in Ghent, where wCAR-T is an innovative blood cancer treatment that harnesses the power of the patient's own immune system. Patients' T-cells are genetically modified to eliminate cancer cells. This cutting-edge technology offers hopeful prospects to patients in whom other therapies are unsuccessful or inadequate.We are therefore working with great enthusiasm on expanding our capacity for CAR-T treatments in Europe, both at our existing site in Beerse and in Ghent, where w
